Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Sujatha S. Menon"'
Autor:
Jamie Aranda, Goundappa K Balasubramani, Ritu Banerjee, Behin Barahimi, Laura A. Binari, David M. Brooks, Anna Burgner, Alexander De Castro-Abeger, Matthew Chinn, Amparo de la Peña, Ally Esch, Mark E. Garcia, Ben Geoffrey A.S., Pravin George, Karen E. Giles, Aarthi Goverdhan, Daniel Griffin, Sylvia Groth, Madihah Hepburn, Nancy Jacobson, Sarah Kim, Charles A. Knirsch, Srinivasan Krishnaswami, Sriram Krishnaswami, Pooja Lal, Susan M. Lopata, Subramani Mani, Natalie N. McCall, William M. McDonald, Sujatha S. Menon, Cullen P. Moran, Sivakumar Nagaraju, Christopher Newey, Mary Patricia Nowalk, Dhyanesh A. Patel, Amelie Pham, Krishna Ramakrishnamenon Prasad, Sathishkumar Ramalingam, John C. Ray, Mythily Srinivasan, Amit K. Srivastava, Jennifer L. Thompson, Thankam Thyvalikakath, Michael F. Vaezi, Andreas Wack, Robert S. Wallis, Charles B. Nemeroff, Jörn-Hendrik Weitkamp
Publikováno v:
Textbook of SARS-CoV-2 and COVID-19 ISBN: 9780323875394
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd94c6282691bb93435208c78346e4ca
https://doi.org/10.1016/b978-0-323-87539-4.00029-4
https://doi.org/10.1016/b978-0-323-87539-4.00029-4
Autor:
Menon S; Pfizer Inc., Groton, CT, USA., Shoji S; Pfizer R&D Japan, Tokyo, Japan., Tsuchiwata S; Pfizer R&D Japan, Tokyo, Japan., Fallon L; Pfizer Canada, Montreal, Quebec, Canada., Kanik K; Pfizer Inc., Groton, CT, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2024 Oct 25. Date of Electronic Publication: 2024 Oct 25.
Autor:
Charles-Schoeman C; University of California Los Angeles, Los Angeles, California., Fleischmann R; Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, Texas., Mysler E; Organización Médica de Investigación, Buenos Aires, Argentina., Greenwald M; Desert Medical Advances, Palm Desert, California., Ytterberg SR; Mayo Clinic, Rochester, Minnesota., Koch GG; The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Bhatt DL; Mount Sinai Health System, New York, New York., Wang C; Pfizer Inc, Groton, Connecticut., Mikuls TR; University of Nebraska Medical Center and Veterans Affairs Nebraska Western Iowa Health Care System, Omaha, Nebraska., Chen AS; Pfizer Inc, Groton, Connecticut., Connell CA; Pfizer Inc, Groton, Connecticut., Woolcott JC; Pfizer Inc, Collegeville, Pennsylvania., Menon S; Pfizer Inc, Groton, Connecticut., Chen Y; Pfizer Inc, Collegeville, Pennsylvania., Lee K; Pfizer Inc, Collegeville, Pennsylvania., Szekanecz Z; University of Debrecen, Debrecen, Hungary.
Publikováno v:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2024 Aug; Vol. 76 (8), pp. 1218-1229. Date of Electronic Publication: 2024 Apr 19.
Autor:
Liu J; Pfizer Inc., Groton, Connecticut, USA., Rowland-Yeo K; Certara UK Limited (Simcyp Division), Sheffield, UK., Winterstein A; University of Florida, Gainesville, Florida, USA., Dagenais S; Pfizer Inc., Winchester, Massachusetts, USA., Liu Q; Office of Clinical Pharmacology, Office of Translational Sciences, CDER, U.S. FDA, Silver Spring, Maryland, USA., Barrett JS; Aridhia Bioinformatics, Glasgow, UK., Zhu R; Genentech, Inc., South San Francisco, California, USA., Ghobadi C; AbbVie, Grayslake, Illinois, USA., Datta-Mannan A; Eli Lilly and Company, Indianapolis, Indiana, USA., Hsu J; Genentech, Inc., South San Francisco, California, USA., Menon S; Pfizer Inc., Groton, Connecticut, USA., Ahmed M; Takeda Pharmaceuticals, Cambridge, Massachusetts, USA., Manchandani P; Astellas Pharma Global Drug Development Inc., Northbrook, Illinois, USA., Ravenstijn P; Affimed GmbH, Mannheim, Germany.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2024 Apr; Vol. 17 (4), pp. e13785.
Autor:
Terranova N; Quantitative Pharmacology, Merck KGaA, Lausanne, Switzerland., Renard D; Full Development Pharmacometrics, Novartis Pharma AG, Basel, Switzerland., Shahin MH; Clinical Pharmacology, Pfizer Inc., Groton, Connecticut, USA., Menon S; Clinical Pharmacology, Pfizer Inc., Groton, Connecticut, USA., Cao Y; Clinical Pharmacology and Translational Medicine, Eisai Inc., Nutley, New Jersey, USA., Hop CECA; DMPK, Genentech Inc., South San Francisco, California, USA., Hayes S; Quantitative Pharmacology & Pharmacometrics, Merck & Co. Inc., Rahway, New Jersey, USA., Madrasi K; Modeling & Simulation, Sanofi, Bridgewater, New Jersey, USA., Stodtmann S; Pharmacometrics, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany., Tensfeldt T; Clinical Pharmacology, Pfizer Inc., Groton, Connecticut, USA., Vaddady P; Quantitative Clinical Pharmacology, Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA., Ellinwood N; Global PK/PD & Pharmacometrics, Eli Lilly, Indianapolis, Indiana, USA., Lu J; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Apr; Vol. 115 (4), pp. 658-672. Date of Electronic Publication: 2023 Oct 06.
Autor:
Karpouzas GA; Division of Rheumatology, Harbor-UCLA Medical Center, and the Lundquist Institute, Torrance, CA, USA., Szekanecz Z; Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Baecklund E; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Mikuls TR; Division of Rheumatology, University of Nebraska Medical Center and VA Nebraska-Western Iowa Health Care System, Omaha, NE, USA., Bhatt DL; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York, NY, USA., Wang C; Inflammation and Immunology, Pfizer Inc, Groton, CT, USA., Sawyerr GA; Inflammation and Immunology, Pfizer Inc, New York, NY, USA., Chen Y; Inflammation and Immunology, Pfizer Inc, Collegeville, PA, USA., Menon S; Inflammation and Immunology, Pfizer Inc, Groton, CT, USA., Connell CA; Inflammation and Immunology, Pfizer Inc, Groton, CT, USA., Ytterberg SR; Division of Rheumatology, Mayo Clinic, Rochester, MN, USA., Mortezavi M; Inflammation and Immunology, Pfizer Inc, 66 Hudson Boulevard, New York, NY 10001, USA.
Publikováno v:
Therapeutic advances in musculoskeletal disease [Ther Adv Musculoskelet Dis] 2023 Nov 06; Vol. 15, pp. 1759720X231201047. Date of Electronic Publication: 2023 Nov 06 (Print Publication: 2023).
Autor:
Zhu R; Clinical Pharmacology, Genentech, Inc., South San Francisco, California, USA., Vora B; Clinical Pharmacology, Genentech, Inc., South San Francisco, California, USA., Menon S; Clinical Pharmacology, Pfizer Inc., Groton, Connecticut, USA., Younis I; Clinical Pharmacology, Gilead Sciences, Inc., Foster City, California, USA., Dwivedi G; Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA., Meng Z; R&D Data and Data Science, Clinical Modeling & Evidence Integration, Sanofi, Cambridge, Massachusetts, USA., Datta-Mannan A; Exploratory Medicine & Pharmacology, Eli Lilly and Company, Indianapolis, Indiana, USA., Manchandani P; Clinical Pharmacology and Exploratory Division, Astellas Pharma Global Development, Northbrook, Illinois, USA., Nayak S; Clinical Pharmacology, Pfizer Inc., Groton, Connecticut, USA., Tammara BK; Clinical Pharmacology, Pfizer Inc., Groton, Connecticut, USA., Garhyan P; Global PK/PD/Pharmacometrics, Eli Lilly and Company, Indianapolis, Indiana, USA., Iqbal S; Biomarker Sciences, Gilead Sciences, Inc., Foster City, California, USA., Dagenais S; Real World Evidence Center of Excellence, Pfizer, Inc., New York, New York, USA., Chanu P; Clinical Pharmacology, Genentech/Roche, Inc., Lyon, France., Mukherjee A; Clinical Pharmacology, Pfizer Inc., Groton, Connecticut, USA., Ghobadi C; Exploratory Medicine & Pharmacology, Eli Lilly and Company, Indianapolis, Indiana, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2023 Oct; Vol. 114 (4), pp. 751-767. Date of Electronic Publication: 2023 Jul 29.
Autor:
Dougados M; Department of Rheumatology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France maxime.dougados@aphp.fr.; INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France., Charles-Schoeman C; Division of Rheumatology, Department of Medicine, University of California Los Angeles, Los Angeles, California, USA., Szekanecz Z; Division of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Giles JT; Division of Rheumatology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA., Ytterberg SR; Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA., Bhatt DL; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York, New York, USA., Koch GG; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Vranic I; Pfizer Ltd, Tadworth, Surrey, UK., Wu J; Pfizer Inc, Groton, Connecticut, USA., Wang C; Pfizer Inc, Groton, Connecticut, USA., Kwok K; Pfizer Inc, New York, New York, USA., Menon S; Pfizer Inc, Groton, Connecticut, USA., Connell CA; Pfizer Inc, Groton, Connecticut, USA., Yndestad A; Pfizer Inc, Oslo, Norway., Rivas JL; Pfizer SLU, Madrid, Spain., Buch MH; Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Publikováno v:
Annals of the rheumatic diseases [Ann Rheum Dis] 2023 Apr; Vol. 82 (4), pp. 575-577. Date of Electronic Publication: 2023 Jan 31.
Autor:
Curtis JR; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham Department of Medicine, Birmingham, Alabama, USA jrcurtis@uabmc.edu., Yamaoka K; Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan., Chen YH; Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan., Bhatt DL; Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Gunay LM; Pfizer Inc, Istanbul, Turkey., Sugiyama N; Pfizer Japan Inc, Tokyo, Japan., Connell CA; Pfizer Inc, Groton, Connecticut, USA., Wang C; Pfizer Inc, Groton, Connecticut, USA., Wu J; Pfizer Inc, Groton, Connecticut, USA., Menon S; Pfizer Inc, Groton, Connecticut, USA., Vranic I; Pfizer Ltd, Tadworth, UK., Gómez-Reino JJ; Department of Rheumatology, Hospital Clínico Universitario, Santiago de Compostela, Spain.
Publikováno v:
Annals of the rheumatic diseases [Ann Rheum Dis] 2023 Mar; Vol. 82 (3), pp. 331-343. Date of Electronic Publication: 2022 Dec 05.
Autor:
Charles-Schoeman C; Division of Rheumatology, Department of Medicine, University of California, Los Angeles, Los Angeles, California, USA ccharles@mednet.ucla.edu., Buch MH; Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Dougados M; Université de Paris; Department of Rheumatology, Hôpital Cochin; Assistance Publique-Hôpitaux de Paris, Paris, France.; INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France., Bhatt DL; Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Giles JT; Division of Rheumatology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA., Ytterberg SR; Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA., Koch GG; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Vranic I; Pfizer Ltd, Tadworth, UK., Wu J; Pfizer Inc, Groton, Connecticut, USA., Wang C; Pfizer Inc, Groton, Connecticut, USA., Kwok K; Pfizer Inc, New York, New York, USA., Menon S; Pfizer Inc, Groton, Connecticut, USA., Rivas JL; Pfizer SLU, Madrid, Spain., Yndestad A; Pfizer Inc, Oslo, Norway., Connell CA; Pfizer Inc, Groton, Connecticut, USA., Szekanecz Z; Division of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Publikováno v:
Annals of the rheumatic diseases [Ann Rheum Dis] 2023 Jan; Vol. 82 (1), pp. 119-129. Date of Electronic Publication: 2022 Sep 22.